Table 2 : Psychosocial Characteristics of Women Screened by Enrollment Status (n=463), Kisumu RingStudy, 2014.


Variable Level Total
(N=463)
n (%)
Enrolled
(N=302)
n (%)
Not Enrolled
(N=161)
n (%)
Enrolled
Prevalence
Prevalence
Ratio (95% CI)
P-value

Motivations for Participation:            

Receive free HIV testing and counseling           0.934

Yes 316 (69.0) 206 (69.1) 110 (68.8) 65.2 1.01(0.87, 1.16) 0.934
No 142 (31.0) 92 (30.9) 50 (31.3) 64.8 Ref. --

Receive free medical care for STIs and common illnesses           0.015*

Yes 356 (77.9) 222 (74.7) 134 (83.8) 62.4 0.84 (0.73, 0.97) 0.015
No 101 (22.1) 75 (25.3) 26 (16.3) 74.3 Ref. --

Receive incentives           0.328

Yes 141 (31.1) 96 (32.7) 45 (28.3) 68.1 0.93 (0.79, 1.08) 0.328
No 312 (68.9) 198 (67.3) 114 (71.7) 63.5 Ref. --

Learn about causes of HIV           0.330

Yes 364 (79.5) 233 (78.2) 131 (81.9) 64.0 1.17 (0.84, 1.63) 0.330
No 94 (20.5) 65 (21.8) 29 (18.1) 69.1 Ref. --

Be able to share with others information learned about HIV           0.134*

Yes 314 (68.9) 197 (66.6) 117 (73.1) 62.7 0.90 (0.78, 1.00) 0.134
No 142 (31.1) 99 (33.4) 43 (26.9) 69.7 Ref. --

Help in controlling the spread of HIV           0.158*

Yes 359 (78.4) 228 (76.5) 131 (81.9) 63.5 0.90 (0.77, 1.04) 0.158
No 99 (21.6) 70 (23.5) 29 (18.1) 70.7 Ref. --

Learn how to avoid HIV risk behaviors           0.036*

Yes 378 (82.9) 239 (80.5) 139 (87.4) 63.2 0.85 (0.73, 0.99) 0.036
No 78 (17.1) 58 (19.5) 20 (12.6) 74.4 Ref. --

Learn about modern family planning methods            

Yes 454 (99.1) 294 (98.7) 160 (100.0) 64.8 -- --
No 4 (0.9) 4 (1.3) 0 (0.0) 100.0 Ref. --

Pregnancy Desires/Intentions            

Pregnancy desired t in the next 12 months           0.747

Yes 32 (7.0) 20 (6.7) 12 (7.5) 62.5 0.96 (0.72, 1.26) 0.747
No 425 (93.0) 278 (93.3) 147 (92.5) 65.4 Ref. --

Pregnancy planned in the next 12 months           0.396

Yes 44 (9.6) 31 (10.4) 13 (8.1) 70.5 1.09 (0.89, 1.34) 0.396
No 414 (90.4) 267 (89.6) 147 (91.9) 64.5 Ref. --

Partner wants her pregnant in the next 12 months           0.133*

Yes 59 (13.1) 43 (14.7) 16 (10.2) 72.9 1.14 (0.96, 1.36) 0.133
No 390 (86.9) 249 (85.3) 141 (89.8) 63.8 Ref. --

Barriers to Modern Contraceptive Method Use            

Too difficult to get           0.230

Yes 76 (17.6) 45 (15.8) 31 (20.8) 59.2 0.88 (0.72, 1.08) 0.230
No 357 (82.4) 239 (84.2) 118 (79.2) 66.9 Ref. --

Unable to afford           0.230

Yes 67 (15.5) 39 (13.7) 28 (18.8) 58.2 0.87 (0.70, 1.08) 0.230
No 366 (84.5) 245 (86.3) 121 (81.2) 66.9 Ref. --

Unsure how to use desired method           0.811

Yes 20 (4.6) 14 (4.9) 6 (4.0) 70.0 -- --
No 413 (95.4) 270 (95.1) 143 (96.0) 65.4 Ref. --

Afraid of side or bad effects           0.653

Yes 65 (15.0) 41 (14.4) 24 (16.1) 63.1 0.96 (0.78, 1.17) 0.653
No 368 (85.0) 243 (85.6) 125 (83.9) 66.0 Ref. --

Partner will/might disapprove           0.592

Yes 36 (8.3) 25 (8.8) 11 (7.4) 69.4 1.06 (0.85, 1.34) 0.592
No 397 (91.7) 259 (91.2) 138 (92.6) 65.2 Ref. --

Community will/might disapprove           0.548

Yes 2 (0.5) 2 (0.7) 0 (0.0) 100.0 -- --
No 431 (99.5) 282 (99.3) 149 (100.0) 65.4 Ref.  

Church/religious community might disapprove           0.170*

Yes 5 (1.2) 5 (1.8) 0 (0.0) 100.0 -- --
No 428 (98.8) 279 (98.2) 149 (100.0) 65.2 Ref. --

Wants children           0.664

Yes 5 (1.2) 4 (1.4) 1 (0.7) 80.0 -- --
No 428 (98.8) 280 (98.6) 148 (99.3) 65.4 Ref. --

Other barriers           1.000

Yes 5 (1.2) 3 (1.1) 2 (1.3) 60.0 -- --
No 428 (98.8) 281 (98.9) 147 (98.7) 65.7 -- --

None, nothing can prevent use           0.878

Yes 178 (41.1) 116 (40.8) 62 (41.6) 65.2 0.99 (1.14, 1.33) 0.878
No 255 (58.9) 168 (59.2) 87 (58.4) 65.9 Ref. --

Study ProceduresAcceptance            

Switch to NuvaRing for 6 months (notional acceptability)


Yes 463 (100.0) 302 (100.0) 161 (100.0) 100.0 -- --

Undergo periodic testing for pregnancy, HIV and STIs


Yes 463 (100.0) 302 (100.0) 161 (100.0) 100.0 -- --

Routine pelvic exam           0.855

High 142 (31.0) 95 (31.9) 47 (29.4) 66.9 1.04 (0.85, 1.27) 0.685
Medium 235 (51.3) 151 (50.7) 84 (52.5) 64.3 1.00 (0.83, 1.21) 0.993
Low 81 (17.7) 52 (17.4) 29 (18.1) 64.2 Ref. --

Sample sizes fluctuate slightly for some variables due to missing data. Some percentages do not sum to 100 because of rounding.
*Variable met p-value ≤0.20 criteria for inclusion in the multivariable analysis.

McLellan-Lemal et al.Research Journal of Women's Health  2016 3:1DOI : 10.7243/2054-9865-3-1